Intensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India.
India
dengue
dengue virus
infection
mosquito-borne diseases
pregnancy
screening program
symptoms
vector-borne infections
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
entrez:
19
3
2020
pubmed:
19
3
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
Mosquitoborne diseases (e.g., malaria, dengue, and chikungunya) are endemic to India and pose diagnostic challenges during pregnancy. We evaluated an intensified short symptom screening program in India to diagnose dengue during pregnancy. During October 2017-January 2018, we screened pregnant women during antenatal surveillance for symptoms of mosquitoborne diseases (fever only, fever with conjunctivitis, fever with rash, or all 3 symptoms) within the previous 15 days. Of 5,843 pregnant women screened, 52 were enrolled and tested for dengue, chikungunya, and Zika viruses by using a Trioplex real-time reverse transcription PCR. Of 49 who had complete results, 7 (14%) were dengue positive. Of these ocular pain was seen in 4 (57%) and conjunctivitis in 7 (100%). Intensified symptom screening using conjunctivitis, in addition to rash, in pregnant women with fever might improve dengue case detection and can be included in routine symptom screening during pregnancy.
Identifiants
pubmed: 32186485
doi: 10.3201/eid2604.191476
pmc: PMC7101120
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
738-743Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI104681
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009574
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI129854
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069465
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD081929
Pays : United States
Références
Obstet Gynecol Surv. 2010 Feb;65(2):107-18
pubmed: 20100360
Obstet Gynecol. 2008 May;111(5):1111-7
pubmed: 18448743
J Vector Borne Dis. 2011 Dec;48(4):210-3
pubmed: 22297282
Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):29-32
pubmed: 19632027
Am J Trop Med Hyg. 2018 Jun;98(6):1826-1832
pubmed: 29692297
Ophthalmol Ther. 2012 Dec;1(1):2
pubmed: 25135582
Can J Infect Dis Med Microbiol. 2017;2017:1671607
pubmed: 29081814
Pediatr Infect Dis J. 2004 Nov;23(11):1042-7
pubmed: 15545860
PLoS Negl Trop Dis. 2016 Apr 06;10(4):e0004577
pubmed: 27050192
PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3226
pubmed: 25299383
PLoS Negl Trop Dis. 2013 May 09;7(5):e2217
pubmed: 23675548
Ginecol Obstet Mex. 2014 Jun;82(6):401-9
pubmed: 25016901
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003812
pubmed: 25996882
Infect Dis Obstet Gynecol. 2016;2016:5046091
pubmed: 27069349
Emerg Infect Dis. 2006 Feb;12(2):285-9
pubmed: 16494756
J Clin Virol. 2006 Sep;37(1):27-33
pubmed: 16843056
Virol J. 2010 Jul 13;7:153
pubmed: 20626851
N Engl J Med. 2014 Sep 11;371(11):1077
pubmed: 25207782
Immunology. 2014 Feb;141(2):143-56
pubmed: 24182427
Nat Commun. 2018 Apr 11;9(1):1391
pubmed: 29643334
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Int J Gynaecol Obstet. 2006 Aug;94(2):131-2
pubmed: 16828097
Lancet Infect Dis. 2016 Jul;16(7):857-865
pubmed: 26949028
Biomed Res Int. 2018 Jan 21;2018:9643083
pubmed: 29607328
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006618
pubmed: 30011275
Lancet Infect Dis. 2016 Jul;16(7):765-766
pubmed: 26949029
Curr Opin Microbiol. 2012 Feb;15(1):36-43
pubmed: 22169833
J Clin Virol. 2007 Feb;38(2):101-5
pubmed: 17142099